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1. INTRODUCTION 
The Objectives of the present investigation: 
The main objectives of this investigation is to develop and validate a RP-
HPLC-PDA method for the estimation of Minocycline hydrochloride in bulk, 
pharmaceutical dosage forms compatible for LC-MS Methods, which is rapid, 
sensitive and economical. 
A. Method development 
i) Optimization of LC conditions  
B. Method Validation 
i) Specificity 
ii) Linearity 
iii) Precision 
iv) Accuracy 
v) Robustness 
vi) LOD and LOQ 
vii)  System Suitability 
viii) Stability of solutions and 
ix) Assay 
HIGH PRESSURE LIQUID CHROMATOGRAPHY (HPLC) 
High performance liquid chromatography is basically a highly improved form of 
column chromatography. It is the most widely used form of chromatography. Instead 
of a solvent being allowed to drip through a column under gravity, it is forced 
through the column under high pressures and this improves separation. The 
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improvements of HPLC have enabled liquid chromatography to match the great 
success of gas chromatography. The separation principles involved may include15 
1) Adsorption 
2) Partition 
3) Ion exchange 
4) Gel permeation 
5) Affinity 
HPLC can be used for both qualitative and quantitative analysis. In qualitative 
analysis, the retention time of the compounds are made use of. In quantitative 
analysis on the other hand, the area under the peak, which is proportional to the 
concentration of the compound is used. 
The HPLC is the method of choice in the field of analytical chemistry, since this 
method is specific, robust, linear, precise and accurate and the limit of detection is 
low and also it offers the following advantages16 
 Speed (many analysis can be accomplished in 20 min or less) 
 Greater sensitivity (various detectors can be employed) 
 Improved resolution (wide variety of stationary phases) 
 Reusable columns (expensive columns but can be used for many 
analysis) 
 Ideal for the substances of low viscosity 
 Easy sample recovery, handling and maintenance. 
 Instrumentation leads itself to automation and quantification (less time 
and less labour), Precise and reproducible 
 Integrator itself does calculations. 
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HPLC Instrumentation 
An HPLC apparatus consists of a pumping system, an injector, a 
chromatographic column, a detector and a data acquisition system as shown in Fig. 
1.2. The mobile phase is supplied from one or several reservoirs and flows through 
the column, usually at a constant rate, and then through the detector17. 
 
Fig. 1.2 Schematic Flow diagram of HPLC 
HPLC can be used for both qualitative and quantitative analysis. In 
qualitative analysis, the retention time of the compounds are made use of. In 
quantitative analysis on the other hand, the area under the peak, which is 
proportional to the concentration of the compound is used. 
Pumps 
In HPLC, there is the need to deliver a constant flow of the mobile phase. 
Pumping systems are thus required to deliver the mobile phase at a constant flow 
rate. Pressure fluctuations are to be minimized as they affect the separation 
efficiency. The pump must be able to provide pressure of up to 6000 psi, pulse free 
output, flow rate ranging from 0.1-10 mL/min, flow control and flow 
reproducibility. Microprocessor controlled systems are capable of accurately 
delivering a mobile phase of either constant (isocratic elution) or varying 
composition (gradient elution), according to a defined program. The delivered flow 
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rate must be independent of the backpressure, even if this changes during a 
separation, which is usually the case with gradient elution. Moreover, the flow 
should be pulse less, especially when a refractive index, conductivity or 
electrochemical detector is used18. 
Injection Systems 
Injection ports are of two basic types 
 Those in which the sample is injected directly into the column and 
 Those in which the sample is deposited before the column inlet and then 
swept by a valve action into the column by the mobile phase. 
On-column injection systems are not as reproducible as the valve injectors and 
generally are used in older or simple HPLC apparatus. Injectors are further grouped 
into manual and auto injectors (auto samplers). The manual injectors require the 
analyst to inject the sample into the valve by a syringe whereas in the auto injectors 
the injection of the sample is done automatically. Auto samplers eliminate variations 
due to the analyst, improving reproducibility19. Auto samplers can be controlled by 
computers and are of value where large number of samples are to be analyzed or 
unattended operation is required. Samples and standards loaded into racks or 
turntables can be run in a predetermined sequence and under different operating 
conditions.  Such devices can also be used for single samples to improve injection 
precision. 
Columns and Stationary Phases 
The column is where the separation process occurs. It is the central 
component of HPLC. There are many types of stationary phases in HPLC depending 
on the particular separation technique being employed. Heavy wall glass, stainless 
steel and plastic are among materials that can withstand high pressures and are used 
to construct HPLC columns20. Columns must not chemically interfere with the 
mobile phase. Usually a short guard column is placed before the column and this 
serves to prolong the life of the column by removing particulate matter and 
contaminants in the solvent. 
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Detectors 
The detector for an HPLC is the component that emits a response due to the 
eluting samples and subsequently signals a peak on the chromatogram. The 
detection of the separated components from the column is based upon the bulk 
property of elute or the solute property of the individual components. There are six 
main types of detectors used for HPLC: refractive index (RI), ultraviolet (UV), 
fluorescence (FL), electrochemical (EC), conductivity (CD), and mass spectrometric 
(MS). Infrared and nuclear magnetic resonance detectors have been used, but they 
suffer from solvent limitations. 
PDA Detector 
 In Photo Diode Array (PDA) detector, the single detecting element of UV 
detector has been replaced by an array of solid state detecting elements (photo-
diodes). These detectors typically have large numbers of diodes in array (256, 512, 
and 1024). In PDA, polychromatic radiation, after passing through the sample, is 
dispersed by a fixed grating and then falls on to an array of photodiodes. Each diode 
measures a narrow band of wavelengths in the spectrum, thus the PDA has parallel 
data acquisition, all points in the spectrum being measured simultaneously. The 
spectrum of each peak in the chromatogram can be stored and subsequently 
compared with standard spectra, which facilitates the identification of peaks.  
This system is superior to other detection systems as: 
 There are no moving parts to wear out, wavelength-resetting errors are reduced 
and the instrument is likely to require less maintenance than does a 
conventional spectrophotometer 
 The ability to make multi wavelength measurements  
 Speed of data acquisition means that various signal-averaging techniques can 
be used to reduce noise  
 Improve sensitivity 
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Peak purity by PDA detector  
When two compounds elute very close to each other, they appear as one 
peak. This can be recognized by a difference of the spectra recorded on the two flags 
of the peak, provided the two compounds have different absorption spectra. When 
PDA is combined with a separating column, three dimensions become available 
wavelength, intensity and chromatographic retention. The spectra obtained must be 
sufficiently different as specified by their correlation coefficients. Even with a value 
under 0.9, superimposed peaks can be calculated and evaluated in a three 
dimensional space without substantial loss in terms of accuracy and precision to 
know the purity of a particular peak.  
PDA Detector was more advantageous compared to other detectors and can 
easily determine all range of wavelengths and analyze purity of compound. At the 
column scouting phase, the use of a photo-diode array (PDA) detector will increase 
the likelihood of detecting degradants with different UV spectrum to that of the API. 
Thus the purpose present method was used the PDA Detector.   
The following diagrams in Fig. 1.3 show the UV and PDA detectors. 
 
 
 
 
 
 
Fig. 1.3 (A) UV Detector; (B) PDA Detector 
Reverse-Phase (RP) Chromatography 
Reverse phase chromatography is the most widely used form of HPLC. In 
reverse phase partition chromatography, the stationary phases are non-polar and thus 
polar mobile phases are required. 
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Stationary Phase 
The stationary phase is silica, chemically bonded through a siloxane linkage 
to low polar functional group. The surface of the support, e.g. the silanol groups of 
silica, is reacted with various silane reagents to produce covalently bound silyl 
derivatives covering a varying number of active sites on the surface of the support21. 
The nature of the bonded phase is an important parameter for determining the 
separation properties of the chromatographic system. Common reverse phase 
materials include octadecylsilane (ODS or C18) and octylsilane (C8). 
Mobile Phase 
The mobile phase generally comprises of water and a less polar organic 
solvent modifier such as methanol or acetonitrile. The solutes in reverse phase 
chromatography are eluted in the order of their decreasing polarities.  Separations in 
these systems are considered to be due to different degrees of hydrophobicity of the 
solute, the less polar solute partitioning to a greater extent into the non-polar 
stationary phase and consequently being retained on the column longer than the 
more polar solute. The rate of elution of the components is controlled by the polarity 
of the organic modifier and its proportion in the mobile phase. The rate of elution is 
increased by reducing polarity e.g. by increasing the proportion of the organic 
solvent or by using acetonitrile instead of methanol. 
Commonly used aqueous phases 
The Table 1.1 given below shows the commonly used aqueous mobile 
phases in the HPLC analysis: 
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Table 1.1 commonly used aqueous phases 
 
Solvent Parameters Relating to HPLC 
The following are some of the solvent parameters that need to be considered 
when choosing a suitable mobile phase for HPLC analysis. 
UV Transparency and UV cut-off 
Most solvents are more transparent to UV down to a certain wavelength and 
below that they totally absorb UV. To be useful with UV detection, the solvent has 
to have a lower UV cut off than the absorption of any of the sample components. In 
general, reverse phase eluents have much lower UV cut-off points than normal phase 
eluents. 
Solvent Miscibility 
Some solvents such as alkanes (e.g. hexane, pentane etc) are very non-polar 
and will not mix with others (such as water), which are highly polar. Since, solvents 
are mixed in HPLC to fine tune the polarity, thereby controlling their eluent 
strength, it is essential that solvents chosen are totally miscible. 
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Viscosity 
HPLC operates in dynamic equilibrium. Almost 90% of the surface area of a 
5micron packing material is inside the pores. So, the lower the viscosity of a solvent, 
the lower the backpressure and the better the mass transfer in and out of the pores. 
This in turn gives better separation efficiency, i.e. sharper peaks. 
Purity 
For HPLC, solvents used require a higher level of purity. For this purpose, 
HPLC grade solvents are required. If these are not available, Analytical (AR) grade 
solvents can be distilled at least once and filtered. The importance of solvent purity 
is that when analyzing small quantities of sample (20µL), impurities in the 20-30mL 
of solvent used during a run can be quite significant22. 
Eluent Strength 
For Reverse Phase HPLC, water is the weakest eluent23. Its eluent strength 
can be modified by adding a non-polar but miscible solvent such as methanol. 
Lesser the polarity of the solvent, greater is the eluent strength. For normal phase 
HPLC, hexane is the weakest eluent and a more polar solvent is added to modify 
eluent strength. These include chloroform, dichloromethane, ethyl acetate, acetone, 
ether etc. 
If a change in eluent composition is made for a selectivity reasons eg. from 
methanol to acetonitrile in RP-HPLC, the ratios must be changed to maintain the 
same eluent strength. 
Toxicity 
Some solvents are more hazardous than others. Toxicity, flammability, 
carcinogenicity amongst others is therefore very essential in selecting solvents for 
HPLC. Some have a very unpleasant odour. Some have a low flash point. It is 
important to be aware of the hazards. 
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Cost: Some solvents are very much more expensive than others. For example, for an 
analysis where methanol or acetonitrile could be used, methanol would be preferred 
when cost is taken into consideration. 
HPLC METHOD DEVELOPMENT:  
A good method development strategy should require only as many 
experimental runs as are necessary to achieve the desired final result.  Finally 
method development should be as simple as possible, and it should allow the use of 
sophisticated tools such as computer modelling.  During initial method development, 
a set of initial conditions (detector, column, mobile phase) is selected to obtain the 
first “scouting” chromatograms of the sample.  In most cases, these are based on 
reversed-phase separations on a C18 column with UV detection
24.  
The important factors, which are to be taken into account to obtain reliable 
quantitative analysis, are 
 Careful sampling and sample preparation.  
 Appropriate choice of the column. 
 Choice of the operating conditions to obtain the adequate resolution of the                       
mixture. 
 Reliable performance of the recording and data handling systems. 
 Suitable integration/peak height measurement technique. 
 The mode of calculation best suited for the purpose. 
 Validation of the developed method. 
Before beginning method development, it is needed to review what is known 
about the sample in order to define the method goals.  The following steps are 
involved in method development. 
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Sample information 
This information is useful for the selection of appropriate sample preparation 
procedures as well as the initial detection and chromatographic modes.  If critical 
data are not available (e.g., pKa, solubility), separate studies should be initiated as 
soon as possible. The chemical structure of the analyte furnishes data on molecular 
weight and the nature of the functional groups. Particular attention should be 
directed to acidic, basic, aromatic, or reactive functional groups from which 
estimates of pKa, solubility, chromophoric, or stability data can be inferred.  If 
sufficient purified reference material is available, solubility studies of the analyte in 
common solvents such as water, alcohol, ether, and hexane should be conducted.  
Toxicity data and Material Safety Data Sheets (MSDS), COA including spectral data 
(MS, NMR, IR, and UV) should be ascertained.  The chemical composition of the 
sample can provide valuable clues for the best choice of initial conditions for an 
HPLC separation. 
Chromatographic mode  
Reversed-phase chromatography is the most common mode for small organic 
molecules.  Note that ionisable compounds (acids and bases) are often separated by 
RPC with buffered mobile phases (to keep the analyte in a non-ionized state) or with 
ion-pairing reagents.   In reverse phase mode, the mobile phase is comparatively 
more polar than the stationary phase.  For the separation of polar or moderately polar 
compounds, the most preferred mode is reverse phase.  The nature of the analyte is 
the primary factor in the selection of the mode of separation.  A second factor is the 
nature of the matrix. Below table gives details of choice of LC mode for different 
molecules: 
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Table 1.2 Choice of LC mode 
Mode Solvent type used Compound type 
Reversed 
Phase 
H2O/Buffer, ACN, 
MeOH 
Neutral or non-ionised compounds 
which can be dissolved in 
water/organic mixtures 
Ion-Pair RP Same as above with 
addition of ion-pair 
reagent 
Ionic or ionisable compounds 
Normal Phase 
 
Organic solvents Mixture of isomers and compounds 
not soluble in organic/water 
mixtures 
Ion exchange 
 
H2O/Buffer Inorganic ions, proteins, nucleic 
acids, organic acids. 
SEC 
 
H2O, THF, CHCl3, 
DMF 
High molecular weight compounds 
 
Sample preparation 
Most samples for HPLC analysis require weighing and /or volumetric 
dilution before injection.  Best results are often obtained when the composition of 
the sample solvent is close to that of the mobile phase since this minimizes baseline 
upset and other problems25. Some samples require a partial separation (pre-
treatment) prior to HPLC, because of need to remove interferences, concentrate 
sample analytes or eliminate “column killers”.  Whereas, special samples are better 
separated under customized conditions given in below table: 
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Table 1.3 Requirements of Sample Selection 
Sample Requirements 
Inorganic ions Detection is primary problem; use ion chromatography. 
Isomers Some isomers can be separated by reversed-phase HPLC 
and are then classified as regular samples; better 
separations of isomers are obtained using either (1) 
normal-phase HPLC or (2) reversed-phase separations 
with cyclodextrin-silica columns. 
Enantiomers These compounds require “chiral” conditions for their 
separation. 
Biological Several factors make samples of this kind “special”: 
molecular conformation, polar functionality, and a wide 
range of hydrophobicity. 
Macromolecules “Big” molecules require column packing’s with large 
pores (>>10-nm diameters); in addition, biological 
molecules require special conditions as noted above. 
 
Selection of Column 
Selection of the column is the first and the most important step in method 
development. The appropriate choice of separation column indicates three different 
approaches26. 
 Selection of separation.  
 The particle size and nature of the column packing. 
 The physical parameters of the column i.e. the length and the diameter. 
Selection of column temperature 
 Always carry out chromatographic separations at ambient temperature.  The 
increase in column temperature generally will result in reduction of asymmetry and 
peak retention. The column temperature between 30°C-80°C shall be adopted if 
necessary.  If a column temperature above 80°C is required, packing material which 
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can with stand to that temperature was preferable.  The below table gives an idea on 
how to select a column: 
Table1.4 Selection of Column27 
Sample  LC mode Column choice 
  
 
Reverse Phase-ion pair 
(allows neutral and charged 
compounds to be 
simultaneously analyzed) 
C18, C8, C6, C4, C2, TMS, CN, amino 
(not for carbonyl compounds), 
phenyl, Hamilton PRP-1 (pH 1-13) 
 
Basic or 
Acidic 
   
     Ion suppression 
 
 
C18, C8, C6, C4, C2, TMS, CN, amino 
(not for carbonyl compounds), 
phenyl, Hamilton PRP-1 (pH 1-13) 
Ionisable  Ion Exchange  
  Anionic  Strong Anion exchange 
  Cationic Strong Cation exchange 
 
      Normal phase Increasing polarity of bonded phases 
diol 
   CN 
Neutral   NH2  
   Silica  
  Reverse phase Alumina, C-18, C-8, phenyl 
 
Selection of Detector 
 The detector was chosen depending upon some characteristic property28 of 
the analyte like UV absorbance, florescence, conductance, oxidation, reduction etc.  
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The characteristics that are to be fulfilled by a detector to be used in HPLC 
determination are, 
 High sensitivity facilitating trace analysis  
 Negligible baseline noise to facilitate lower detection  
 Large linear dynamic range 
 Low dead volume 
 Ease in calibration and standardization 
 Inexpensive to purchase and operate 
Pharmaceutical ingredients do not absorb all UV light equally, so that selection 
of detection wavelength is important. An understanding of the UV light absorptive 
properties of the organic impurities and the active pharmaceutical ingredient is very 
helpful. Generally LC equipped with PDA detector was the first choice. 
For the greatest sensitivity λmax should be used.  Ultra violet wavelengths 
below 200nm should be avoided because detector noise increases in this region.  
Higher wavelengths give greater selectivity. 
METHOD VALIDATION 
Analytical method validation is a process of performing several tests 
designed to verify that an analytical test system is suitable for its intended purpose 
and is capable of providing useful and valid analytical data. A validation study 
involves testing multiple attributes of a method to determine that it can provide 
useful and valid data when used routinely. There are several parameters that are 
considered in the method validation process as per International Conference of 
Harmonization (ICH) Guidelines and are as follows: 
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Method validation 
a. Specificity  
b. Linearity 
c. Precision 
i. System Precision 
ii. Method Precision 
d. Accuracy 
e. Robustness 
f. LOD and LOQ 
g. System suitability 
h. Stability of the solution 
i. Assay 
Specificity  
Specificity studies were carried for the pure drug and drug product by 
comparing the 3D plots with blank and placebo. Peak purity tests were also carried 
out to show that the analyte chromatographic peak is not attributable to more than 
one component as the impurities are not available by purity index data. The data was 
shown in Figures 3.1- 3.3. 
Linearity  
       A linear relationship was evaluated across the range of the analytical procedure 
with a minimum of five concentrations. A series of combination standard dilutions 
were prepared over a concentration range of 10-50μg/mL for Minocycline 
hydrochloride from stock solution of the pure drug and injected in triplicate. 
Linearity is evaluated by a plot of peak areas as a function of analyte concentration, 
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and the test results were evaluated by appropriate statistical methods where by slope, 
intercept, and regression (R2) and correlation coefficient (R) were calculated and the 
data was given in Table 3.1 and shown in Figures 3.4-3.10. 
Precision 
Precision is the measure of closeness of the data values to each other for a 
number of measurements under the same analytical conditions. Repeatability was 
assessed by using a minimum of six determinations at 100 % of the test 
concentration (30μg/mL of Minocycline hydrochloride). The standard deviation and 
the relative standard deviation were reported for precision. Less than 2 % RSD for 
peak areas and 1% RSD for retention times of the drug indicates the precision of the 
developed method and the data was presented in Table 3.2, 3.3 and shown in Figures 
3.11-3.24.  
Accuracy 
Accuracy was established across the specified range of the analytical 
procedure. To ascertain the accuracy of the proposed method recovery studies were 
performed by the standard addition method by spiking 80%, 100%, 120% of the 
known quantities of standards within the range of linearity to the synthetic solution 
of drug product (10μg/mL of Minocycline hydrochloride) and these mixture 
solutions were analyzed by developed method in triplicate. The % Recovery and the 
% RSD were calculated for both the drugs at each level of addition and the data was 
given in Table 3.4 and depicted in Figures 3.25-3.33. 
LOD and LOQ 
LOD and LOQ were calculated based on calibration curves. They were 
expressed as LOD = (3.3 ×σ)/m; LOQ= (10.0×σ)/m (Where,  is the standard 
deviation of the y-intercepts of the three regression lines and m is mean of the slopes 
of the three calibration curves). 
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Robustness  
To determine the robustness of the method developed, the experimental 
conditions were deliberately altered and the chromatographic parameters viz., tailing 
factor, no. of theoretical plates were recorded. The flow rate of the mobile phase was 
1.2mL/min. To study the effect of flow rate, on the proposed method, the flow rate 
was changed to 10% and the effect of wavelength was studied by changing 
wavelength by ±1nm and the data was given in Table 3.5 and shown in Figures 3.34-
3.39. 
System Suitability  
Increment volumes (10-50μL) of standard concentration were injected to 
assess the system suitability. The data was given in Table 3.6 and shown in Figures 
3.40-3.45. 
Stability of the solution  
The stability of the stock and standard solutions were determined by 
analyzing the samples under refrigeration (8±1°C) at different time intervals up to 24 
hours. The data was given in Table 3.7 and shown in Figures 3.46-3.47. 
Assay   
Twenty tablets were weighed and finely powdered, the powder blend 
equivalent to 10mg of Minocycline hydrochloride was accurately weighed and 
transferred into a 10 mL volumetric flask and dissolved in methanol and vortexed 
for 5 min and volume was adjusted up to the mark with methanol to get 1mg/mL of 
Minocycline hydrochloride. The above solution was centrifuged and then filtered 
using Nylon disposable syringe filter (0.45 µm) and the 10μL of filtrate was diluted 
with ammonium acetate to 1mL to get a solution containing 10μg/mL of 
Minocycline hydrochloride. The solution was injected in triplicate and analyzed. 
The amount present in each tablet was quantified by comparing the area of standard 
Minocycline hydrochloride with that of the sample. The data was given in Table 3.8 
and shown in Figure 3.48-3.50.  
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Calculation:    
Amount of Minocycline hydrochloride per tablet was calculated by using the 
following formula: 
                                     AT        DS         P 
Minocycline hydrochloride        =      ------ × ------ × ------ 
(mg/ tablet)                   AST       DT       100 
Where, 
AT = Average area counts of injections for Minocycline hydrochloride  
  peak in the chromatogram of sample solution. 
AST           = Average area count of three replicate injections for Minocycline 
  hydrochloride Peak in the chromatogram of standard solution                           
DS          = Dilution factor of standard solution  
DT          = Dilution factor of sample solution 
P = Percentage purity of working standard used 
                                            Content of each Minocycline hydrochloride (mg/tablet)             
     % Labelled Amount =                                                                                      × 100 
                                                                Label claim, in mg 
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2. LITERATURE REVIEW  
The analytical methods reported so far for the estimation of Minocycline 
hydrochloride individually include HPLC3-5, UPLC6, UV Spectrophotometry7,8, LC-
MS/MS9,10 etc. Following is the summary of the HPLC, UPLC methods for the 
analysis of Minocycline hydrochloride in bulk/formulation and in biological fluids. 
Report on Literature Survey: 
Literature survey reveals that only few HPLC methods were reported for the 
quantitative determination of Minocycline hydrochloride but there were no validated 
RP-HPLC/PDA methods reported for the estimation of Minocycline hydrochloride 
in bulk, pharmaceutical dosage forms. 
Hence, the present investigation was aimed at developing a validated RP-
HPLC-PDA method for the analysis of Minocycline hydrochloride in bulk, 
pharmaceutical dosage forms which is LC-MS compatible, accurate, precise and 
economical.  
1. Alka Agarwal et., al27, was developed in simple, fast, precise and accurate high 
performance liquid chromatographic method has been developed for the 
quantitative estimation of minocycline hydrochloride from powder for oral 
suspension formulation. The method was developed using acetonitrile : 
Phosphate buffer in the proportion of 25 : 75 v/v at flow rate of 0.5 mL/min as 
mobile phase. The separation was carried out on Inertsil ODS 3V C18 (250 mm 
x 4.6 mm, 5 µm) column and the eluents were detected at 280 nm. The linearity 
was observed in the concentration range of 100 to 900 µg/mL of minocycline 
hydrochloride. The LOD and LOQ of the method were 0.816 and 2.474 µg/mL, 
respectively. 
2. S. Talegaonkar et., al28  , HPTLC method has been established for determination 
of minocycline in human plasma. Chromatography was performed on 
aluminium plates coated with silica gel 60F254; the mobile phase was 
methanol–acetonitrile–isopropanol–water 5:4:0.5:0.5 (v/v). Densitometric 
analysis was performed at 345 nm. The method is rapid (single-step extraction 
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with methanol), sensitive (limit of quantification 15.4 ng per zone), precise (CV 
≤ 4.61 %), accurate (drug recovery 95.08–100.6%), and linear over the range 
100–1200 ng per zone. Recovery of minocycline from plasma samples was 95.8 
± 4.5%. The halflife of minocycline in plasma was 9.9 h at 4°C and 6.3 h at 
20°C. Minocycline is stable in human plasma for at least two months at −20°C 
and can tolerate two freeze–thaw cycles with losses. 
3. Wenna Shi, Zuozhong chen, et., al41, Combination therapy can be used for the 
treatment of fungal infections, especially for those caused by antifungal-
resistant fungi. In the present study, in vitro interactions and mechanisms 
between fluconazole and minocycline against Candida albicans were evaluated. 
The nature of the interactions determined by spectrophotometric method in a 
checkerboard assay was interpreted using nonparametric models of fractional 
inhibitory concentration index (FICI) and percentages of growth difference 
(ΔE). In the mechanism study, we evaluated the potential activity of 
minocycline on fluconazole penetrating the C. albicans biofilm. Furthermore, 
the effect of fluconazole and minocycline alone and in combination on the 
cellular calcium balance, as well as on the uptake and efflux of fluconazole 
were evaluated. It was found that fluconazole can work synergistically with 
minocycline against fluconazole-resistant C. albicans; the minimum inhibitory 
concentration of fluconazole decreased from 512 to 2 μg mL−1 when 
fluconazole and minocycline were given in combination, with an FICI of 0.035 
and 0.064 and high-percentage synergistic interactions of 1250% and 988% for 
the two resistant strains. The mechanism of action was suggested to be the 
enhancement of minocycline on fluconazole penetrating biofilm, and inducing 
the intracellular calcium release, instead of impacting on the uptake and efflux 
of fluconazole. 
4. Victoria F. Samanidou et., al30, A high-performance liquid chromatographic 
method with diode-array detection, at 351 nm, was developed and validated for 
the determination of five tetracyclines (TCs): minocycline, tetracycline, 
oxytetracycline, chlortetracycline, and doxycycline in bovine muscle. Samples 
were macerated with a buffer solution, centrifuged, and purified using Abselut 
Nexus SPE cartridges. The separation of the examined TCs was achieved on an 
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Inertsil ODS-3 5 μm, 250×4 mm analytical column, at ambient temperature. A 
multistep gradient elution was followed using 0.05 M oxalic acid and CH3CN, 
at a flow rate of 1.65 mL/min. The procedure was validated according to the 
European Union regulation 2002/657/EC determining selectivity, stability, 
decision limit, detection capability, accuracy, and precision. 
5. Gaurav K  Jain et., al34, high-performance thin-layer chromatographic (HPTLC) 
me-thod has been established for determination of minocycline in human plas-
ma. Chromatography was performed on aluminium plates coated with silica gel 
60F 254 ; the mobile phase was methanol–acetonitrile–isopropanol–wa-ter 
5:4:0.5:0.5 (v/v). Densitometric analysis was performed at 345 nm. The method 
is rapid (single-step extraction with methanol), sensitive (limit of quantification 
15.4 ng per zone), precise (CV ≤ 4.61 %), accurate (drug recovery 95.08–
100.6%), and linear over the range 100–1200 ng per zone. Recovery of 
minocycline from plasma samples was 95.8 ± 4.5%. The half-life of 
minocycline in plasma was 9.9 h at 4°C and 6.3 h at 20°C. Minocy-cline is 
stable in human plasma for at least two months at −20°C and can tolerate two 
freeze–thaw cycles with losses <10%. 
6. M.Thakkar et., al33, precise and accurate high performance liquid 
chromatographic method has been developed for the quantitative estimation of 
minocycline hydrochloride from powder for oral suspension formulation. The 
method was developed using acetonitrile: Phosphate buffer in the proportion of 
25: 75 v/v at flow rate of 0.5 mL/min as mobile phase. The separation was 
carried out on Inertsil ODS 3V C18 (250 mm x 4.6 mm, 5 μm) column and the 
eluents were detected at 280 nm. The linearity was observed in the 
concentration range of 100 to 900 μg/mL of minocycline hydrochloride. The 
LOD and LOQ of the method were 0.816 and 2.474 μg/mL, respectively.  
7. Adapa V.S.S Prasad et., al35, was developed in Sensitive spectrophotometric 
methods (M1–M4) by the application of oxidative coupling and diazocoupling 
reactions for the assay of minocycline (MC) in pure form and pharmaceutical 
formulations have been described. Methods M1 and M2involve the oxidative 
coupling reactions of MC with 3-methyl-2-benzothiozolinone hydrazone 
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(MBTH) (method M1, λmax 440 nm) or 4-aminophenazone (4-AP) (method 
M2, λmax 520 nm) in the presence of periodate. Methods M3 and M4 are based on 
the formation of diazocoupling products of MC with diazotised p-nitroaniline 
(DPNA) (method M3, λmax 420 nm) or diazotised sulfanilic acid (DSAC) 
(method M4, λmax 420 nm). Regression analysis of Beer's law plot showed good 
correlation in the concentration range of 8–48, 20–120, 4–20 and 8–40 μg 
ml−1 for methods A, B, C and D, respectively. 
8. E. Rosier, et., al29 ,  was developed in  human and animal remains by means of 
analysis of volatile compounds released during decomposition is impossible 
since no volatile marker(s) specific for human decomposition has been 
established today. Hence, the identification of such a marker for human 
decomposition would represent great progression for the discovery of buried 
cadavers by analytical techniques. Cadaver dogs can be trained more 
efficiently, the understanding of forensic entomology can be enhanced, and the 
development of a portable detection device may be within reach. This study 
describes the development and validation of a new analytical method that can 
be applied in the search of such (a) specific marker(s). Sampling of the volatile 
compounds released by decomposing animal and human remains was 
performed both in a laboratory environment and outdoors by adsorption on 
sorbent tubes. Different coatings and several sampling parameters were 
investigated. 
9. Slavica M.SunarićabMarko S.Denić et., al31, was developed in the present paper 
reports the development and validation of an analytical method for doxycycline 
quantification in human seminal fluid by HPLC with UV detection. The 
separation of doxycycline was achieved at 40 °C on a reversed-phase C18 
column using isocratic elution. The mobile phase consisted of acetonitrile (A) 
and water buffered at pH 2.5 with a concentrated orthophosphoric acid (B) in 
the volume ratio of 20:80 (v/v), respectively. The detection was performed at 
350 nm. As an internal standard (IS), tetracycline was used. The proposed 
method involves the extraction of doxycycline from seminal fluid based on 
acidic precipitation of the proteins using perchloric acid. The method showed 
good intra- and inter-day precisions (RSD < 7.0%), good accuracy (recovery for 
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doxycycline > 80%), and high correlation coefficient (r = 0.998) for standards 
subjected to the entire procedure. The detection and quantification limits were 
0.087 μg/ml and 0.264 μg/ml. The developed method was used to analyze 
doxycycline in the seminal fluids obtained from male subjects who were treated 
with doxycycline-hyclate. The mean doxycycline concentrations of 
0.89 ± 0.07 μg/ml and 0.45 ± 0.26 μg/ml were detected in seminal fluid after 
6 h and 12 h, respectively. 
10. S.Sharma et., al32, New, simple, precise, and accurate HPTLC method for 
simultaneous quantitation of Metronidazole (MET) and and Tetracycline 
hydrochloride (TET) as the bulk drug and in capsule dosage forms have been 
developed. Chromatographic separation of the drugs was performed on 
aluminium plates precoated with silica gel 60 F254 as the stationary phase and 
the solvent system consisted of benzene: ethyl acetate: toluene: methanol: 
glacial acetic acid (9.5:2.0:5.0:1.5:0.5 v/v/v/v/v),Densitometric evaluation of 
the separated zones was performed at 254 nm. The two drugs were satisfactorily 
resolved with R f values of 0.43 ± 0.02 and 0.74± 0.02 for MET and TET, and 
0.29 Ofloxacin (OF) respectively. 
11. Naidong Weng et., al36 was developed in liquid chromatographic methods laid 
out for the analysis of minocycline hydrochloride in the British Pharmacopoeia 
1988, the United States Pharmacopeia XXII and the Pharmacope Franaise 10 
were examined. The major difference between these methods lies in the 
adjustment of the pH of the mobile phase. The analyst has to obtain the right pH 
of the mobile phase for his available column. This was found to be a less than 
easy task for the occasional analyst. Other disadvantages observed were poor 
solubility of the components of the mobile phase, reduced sensitivity due to UV 
absorbance by the mobile phase, rather high back pressure, the elution order for 
9-minocycline depending on the brand of stationary phase, and above all, poor 
stability of the stationary phase.       
12. Victoria F Samanidou et., al37 confirmatory high-pressure liquid 
chromatographic method for the determination of nine tetracyclines in Sparus 
aurata (gilthead seabream) muscle tissue is developed and presented herein. 
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Tetracycline, 4-epi-tetracycline, oxytetracycline, 4-epi-oxytetracycline, 
chlortetracycline, 4-epi-chlortetracycline, doxycycline, methacycline and 
demeclocycline were separated on a Kromasil, C18 (250 mm × 4 mm, 5 μm) 
analytical column by gradient elution with a mobile phase consisting of 0.001 
M ethylenediaminetetraacetic acid/sodium salt and acetonitrile at 25°C. Diode 
array detection with monitoring at 280 nm (for the determination of 
chlortetracycline, 4-epi-chlortetracycline, methacycline and demeclocycline) 
and 355 nm (for tetracycline, 4-epi-tetracycline, oxytetracycline, 4-epi-
oxytetracycline and demeclocycline) was applied for peak identification and 
quantification of analytes.  
13. Mukesh Kumar Raikwar et., al38 To develop and validate method for 
tetracycline antibiotics and their epimers in marine products as per EU 
commission (2007/657/EC). Now a day it becomes necessary to detect 
tetracycline as well as their epimers at EUMRL level with high confidence so 
that effort was made to separate and detect tetracyclines (tetracycline, 
oxytetracycline, doxytetracyclinea and chlortetracycline) and their epimers 
(epitetracycline, epichlortetracycline and epioxytetracycline). Here isomers 
have the same molecular weight and somewhat chemical nature too so that long 
run time was used to get separate peaks. For sample extraction Mcvalline buffer 
was used and then extract was purified by passing through a C18 solid phase 
extraction (SPE) column. The prepared samples were analyzed on LC/MSMS. 
Tetracycline antibiotic residues in marine products were analyzed. The recovery 
rates of seven tetracyclines in sample preparation ranged from 77.03 % to 89.95 
% in fortified blanks; the coefficient variation were between 0.35 % and 2.89 
%. The Decision limits (CCα) were 102.93 to 104.23 ng/g and Detection 
Capability (CCβ) was 105.78 to 108.26 ng/g.       
14.   Ewelina Patyra et., al39, A chromatographic procedure for the determination of 
oxytetracycline (OTC), tetracycline (TC), chlorotetracycline (CTC), and 
doxycycline (DC) in medicated feedingstuffs was developed. Samples were 
extracted with 0.01 M citric buffer/acetonitrile (pH 3.0) and further purified 
with 0.45 μm syringe filters. The purified extract was separated on Thermo 
column C18, 150 × 4 mm, 5 μm and detection was carried out at 360 nm for 
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OTC, and TC, 370 nm for CTC, and 350 nm for DC. TCs were eluted with a 
mobile phase of 0.03 M SDS/7 % 1-butanol/0.02 M oxalic acid/NaOH at pH 
2.5. This method provided average recoveries of 80.4 % to 100.2 %, with CVs 
of 0.5 % to 6.6 % in the range of 50 to 1500 mg/kg OTC, TC, CTC, and DC in 
feeds. The linearity for the four TCs was determined by high-performance 
liquid chromatography-diode array detector (HPLC-DAD) in the range 10–
300 μg/mL (50–1500 mg/kg), with a linear correlation coefficient (R) > 0.99. 
The LOD and LOQ for TCs in pig and poultry feeds ranged from 4.0 to 10.7 
and 4.7 to 12.6 mg/kg, respectively. 
15. Emad M. Hussien et., al40, Novel reversed-phase HPLC method was developed 
and validated for the assay of tetracycline hydrochloride and the limit of 4-
epianhydrotetracycline hydrochloride impurity in tetracycline hydrochloride 
commercial bulk and pharmaceutical products. The method employed L1 
(3 µm, 150 × 4.6 mm) columns, a mobile phase of 0.1% phosphoric acid and 
acetonitrile at a flow rate of 1.0 mL/min, and detection at 280 nm. The 
separation was performed in HPLC gradient mode. Forced degradation studies 
showed that tetracycline eluted as a spectrally pure peak and was well resolved 
from its degradation products. The fast degradation of tetracycline 
hydrochloride and 4-epianhydrotetracycline hydrochloride in solution was 
retarded by controlling the autosampler temperature at 4 °C and using 0.1% 
H3PO4 as diluent. The robustness of the method was tested starting with the 
maximum variations allowed in the US Pharmacopeia (USP) general 
chapter Chromatography <621>.  
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3. OBJECTIVES AND PLAN OF WORK 
In modern days usage of large number of drugs is increased to save the life 
of human beings, to control the spreading of large number of diseases around the 
world. 
A drug is having many physical and chemical properties that show variation 
in properties at various stages of bulk drug manufacturing, synthesis stage and 
formulation stage. These properties are estimated by qualitative and quantitative 
approach by using various number of new techniques. 
Modern pharmaceutical industries generally require precise analytical 
instruments at very low concentrations with various types of instruments like HPLC, 
LC-MS, UP-LC, GC, NMR and IR1. Using these instrumental techniques high 
resolution can be achieved. There is continuous change in techniques in the method 
development for various numbers of drugs for the quantification purpose are used 
presently. There are often a huge number of alternative methods for solving any 
analytical method development, but by understanding the advantages and limitations 
of the various tools we can choose the most appropriate instrumental method to 
achieve the limitations in sensitivity, precision, and accuracy. 
Various number of combination drug formulations are released in to the market to 
reduce the side effects and to minimize the drug toxicity. In these formulations 
resolution has to be done to determine the content of drug present in it. The 
advanced instruments like LC-MS and UP-LC are highly economic to develop the 
new methods used in industry. 
Many analytical techniques are used in the pharmaceutical industry to 
characterize a diversity of substances including active ingredients, impurities, 
counter-ions, excipients, extractable and process contaminants. HPLC is widely used 
in the pharmaceutical industry for quantitative analysis of a broad range of 
substances. While UV remains a primary detection technique, many analytes of 
interest (e.g., active pharmaceutical ingredient (API), impurities, counter-ions, 
excipients, extractables, and contaminants) lack a sufficient UV chromophore. 
Furthermore, the response obtained with UV and many other detectors is highly 
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dependent on analyte properties. This posses significant challenges since individual 
standards are not always available, or are impractical, to use for calibration. Hence 
number of companies are mainly focusing on HPLC methods which are simple, 
precise, economical and efficient for the estimation purpose. 
The Validation of Analytical Procedures (Q2R1) issued by International 
Conference on Harmonization (ICH) requires that analytical test procedures should 
be fully validated and the analytical procedures should be investigated in order to 
ensure the quality of the drug substance or drug product2. 
The main aim of the present investigation is to develop a validated RP-
HPLC-PDA method for the estimation of Minocycline Hcl in bulk, pharmaceutical 
dosage form, rapid, sensitive and cost effective method. 
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4. DRUG PROFILE 
 MINOCYCLINE HYDROCHLORIDE 
Minocycline hydrochloride is a Broad spectrum tetracycline antibiotic. It is 
used to treat acne vulgaris. Chemically it is (4S,4aS,5aR,12aR)-4,7-
bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-3,4,4a,5,5a,6,12,12a-
octahydrotetracene-2- carboximidicacid hydrochloride. 
 
Fig. 1.1 Chemical structure of Minocycline hydrochloride 
Physicochemical properties of minocycline hydrochloride 
Description : Broad spectrum tetracycline antibiotic 
Mol. Mass : 493.937g/mol 
Mol. Formula : C23H28ClN3O7 
Melting point : 205-2100C 
Pka : Strongest Acidic (-1.1), Strongest Basic (10.87) 
Solubility : Sparingly soluble in water, slightly soluble in alcohol. It dissolves in 
solutions of alkali hydroxides and carbonates 
Storage                   : In air tight container, protected from light. 
Brand Names         : Minocin, Solodyn, Dynacin 
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Pharmacological properties of minocycline hydrochloride 
Mechanism of action13 
Minocycline passes directly through the lipid bilayer or passively diffuses 
through porin channels in the bacterial membrane. Tetracyclines like minocycline 
bind to the 30S ribosomal subunit, preventing the binding of tRNA to the mRNA-
ribosome complex and interfering with protein synthesis. 
Pharmacokinetics14 
Absorption : Rapidly absorbed from the gastrointestinal tract and 
absorption is not significantly impaired by ingestion of food 
or milk. Oral bioavailability is 100%. 
Protein binding   55  : 55% to 76 
Metabolism 
Excretion   
: Hepatic  
: Mostly fecal rest renal 
Half life : 11-22hrs 
Route 
administration 
: Oral, i.v 
Dose  : 50 to 100mg 
Indications: 
  For the treatment of infections caused by susceptible strains of 
microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus 
group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper 
respiratory tract infections caused by Streptococcus pneumoniae and for the 
treatment of asymptomatic carriers of Neisseria meningitidis. 
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Adverse effects:    
The common side effects include nausea, vomiting, diarrhea, dizziness, 
drowsiness, mouth sores,    and cough, discoloration of skin and nails, headache. 
Other side effects include 
 kidney problems - little or no urinating; painful or difficult urination; 
swelling in your feet or ankles; feeling tired or short of breath; 
 liver or pancreas problems - nausea, vomiting, upper stomach pain that may 
spread to your back, tired feeling, loss of appetite, dark urine, clay-colored 
stools, jaundice (yellowing of the skin or eyes); 
 increased pressure inside the skull - severe headaches, ringing in your ears, 
dizziness, vision problems, pain behind your eyes; 
 signs of inflammation in your body - swollen glands, flu symptoms, easy 
bruising or bleeding, severe tingling or numbness, muscle weakness, chest 
pain, new or worsening cough with fever, trouble breathing; or  
 severe skin reaction - fever, sore throat, swelling in your face or tongue, 
burning in your eyes, skin pain, followed by a red or purple skin rash that 
spreads (especially in the face or upper body) and causes blistering and 
peeling. 
Toxicity 
Minocycline has been observed to cause a dark discoloration of the thyroid 
in experimental animals (rats, minipigs, dogs and monkeys). In the rat, chronic 
treatment with minocycline has resulted in goiter accompanied by elevated 
radioactive iodine uptake and evidence of thyroid tumor production. Minocycline 
has also been found to produce thyroid hyperplasia in rats and dogs. LD50=2380 
mg/kg (rat, oral), LD50=3600 mg/kg (mouse, oral). 
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5. MATERIALS AND METHODS 
Reagents and Chemicals 
 Minocycline hydrochloride (Dr. Reddy’s Laboratories. Hyderabad) 
 Water - HPLC grade (E. Merck, Mumbai) 
 Ammonium Acetate- HPLC grade (E. Merck, Mumbai) 
 Methanol- HPLC grade (E. Merck, Mumbai) 
 Acetonitrile - HPLC grade (E. Merck, Mumbai)  
 Sodium Lauryl Sulphate  (Loba Chemie, Mumbai) 
 Divaine tablets 50mg (AH3445) were commercially purchased. 
Instrumentation 
Quantitative RP-HPLC was performed on a high pressure gradient High 
Performance Liquid Chromatography (Shimadzu HPLC, class VP series) with two 
LC-20AD pumps, SIL-20A auto sampler was used with 200µL loop volume, 
programmable variable wavelength PDA detector SPD-M20A VP, and Agilent 
Eclipse C18 column (150×4.6 mm and 5 µm particle size). The HPLC system was 
equipped with “LC-Solution” software to acquire and process the data. The 
instrument is shown in the following Fig. 2.1. 
 
Fig. 2.1 Shimadzu Prominence HPLC with SIL-20A auto sampler and SPD-M20A 
VP PDA detector 
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Preparation of stock and standard solutions 
Standard stock solution of Minocycline hydrochloride 1 mg/mL was 
prepared using HPLC grade methanol 10 mg of Minocycline hydrochloride was 
dissolved in 10 mL of methanol  (1 mg/mL) solution 
 
Appropriate volumes (10-50 μL of Minocycline hydrochloride) of this stock 
solution were then further diluted with ammonium acetate to 1 mL to get the 
required concentrations of standard solutions at a concentration range of 10-50 
µg/mL. 
METHOD DEVELOPMENT 
The objective of this experiment was to optimize the RP-HPLC-PDA method 
for the estimation of Minocycline hydrochloride, based on the literature survey 
made.  
In developing this method, a systematic study of effects of various parameters was 
under taken by varying one parameter at a time and controlling all other parameters. 
A) Selection of Stationary phase 
B) Selection of Mobile phase 
C)  Selection of wavelength 
The following trials were carried out in order to optimize the LC conditions for the 
estimation of Minocycline hydrochloride in bulk and pharmaceutical dosage forms 
for further validation of the method conditions and in vitro dissolution samples 
analysis 
Trial-1 
The following are the chromatographic conditions used in the initial trial. 
The mobile phase optimization was initiated using HPLC water and methanol as 
organic phase. 
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Preparation of 0.02%V/v/v Formic acid: 0.02ml of formic acid was accurately 
weighed, transferred to a clean dry volumetric flask containing 100 mL of HPLC 
grade water, dissolved and the volume was adjusted to 500 mL with the same 
solvent. 
Chromatographic conditions: 
Mobile phase HPLC Water:Methanol(50:50%v/v) 
Flow rate 1.0 mL/min 
Column Inertsil ODS Column (150x4.6 mm, 5µ) 
Detector wave length 220 nm 
Column temperature Ambient 
Injection volume 10 L 
Run time 15 min 
Diluent Water 
 
         Below is the minocycline hydrochloride chromatogram obtained with these 
conditions: 
0.0 2.5 5.0 7.5 10.0 min
-10.0
-7.5
-5.0
-2.5
0.0
2.5
mAU
232nm,4nm (1.00)
 
 Fig.  2.2 Trial - 1 Chromatogram of standard Minocycline hydrochloride 
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S. No Name of Peak Retention time (min) 
1 Minocycline 
hydrochloride 
No peak eluted 
 
Observation: 
 Under these conditions, no peak eluted  
Trial-2 
 In this trial, except for the change in organic phase to 0.02%V/v/v Formic 
acid:Acetonitrile in ratio (80:20v/v) and all other conditions were maintained as 
above. 
Chromatographic conditions: 
Mobile phase 0.02%V/v/v Formic acid:Acetonitrile 
(80:20v/v) 
Flow rate 1.0 mL/min 
Column Inertsil ODS Column (150x4.6 mm, 5µ) 
Detector wave length 220 nm 
Column temperature Ambient 
Injection volume 10 µL 
Run time 7 minutes 
Diluent Water 
 
         Below is the minocycline hydrochloride chromatogram obtained with these 
conditions:  
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Fig. 2.3 Trial - 2 Chromatogram of standard Minocycline hydrochloride 
S.NO Name of the peak Retention time (min) 
1 Minocycline hydrochloride 3.36 
 
Observation: 
 Under these minocycline hydrochloride conditions, eluted with retention 
time of 3.36min but peak fronting was observed. 
Trial-3 
In this trial, except for the change in the ratio of organic phase (85:15 v/v) all 
the other conditions were maintained as above. 
Chromatographic conditions:  
Mobile phase 0.02%V/v/v Formic acid:Acetonitrile (85:15v/v) 
Flow rate 1.0 mL/min 
Column Inertsil ODS Column (150x4.6 mm, 5µ) 
Detector wave length 220 nm 
Column temperature Ambient 
Injection volume 10 µL 
Run time 10 min 
Diluent Water 
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 Below is the minocycline hydrochloride chromatogram obtained with these 
conditions: 
0.0 2.5 5.0 7.5 min
0.0
2.5
5.0
7.5
10.0
12.5
mAU
265nm,4nm (1.00)
3
.5
0
9
 
Fig.  2.4 Trial - 3 Chromatogram of standard Minocycline hydrochloride 
S.NO Name of the peak Retention time (min) 
1 Minocycline 
hydrochloride 
3.50 
 
Observation: 
 Under these conditions, Minocycline hydrochloride eluted at retention 
time of 3.50min, but the peak symmetry was not good and baseline drift was 
observed. By observing this it can be concluded that by increasing the ratio of 
organic phase, retention time was increased but the symmetry could not be 
improved. 
Trial-4 
In this trial, except for the change in the ratio of organic phase (90:10 v/v) 
and all the other conditions were maintained as above. 
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Chromatographic conditions:  
Mobile phase 0.02%V/v/v Formic acid:Acetonitrile (90:10v/v) 
Flow rate 1.0 mL/min 
Column Inertsil ODS Column (150x4.6 mm, 5µ) 
Detector wave length 220 nm 
Column temperature Ambient 
Injection volume 10 µL 
Run time 7 min 
Diluent Acetonitrile 
                
 Below is the minocycline hydrochloride chromatogram obtained with 
these conditions: 
0.0 1.0 2.0 3.0 4.0 5.0 6.0 min
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    Fig. 2.5 Trial - 4 Chromatogram of standard Minocycline hydrochloride 
S.NO Name of the peak Retention time (min) 
1 Minocycline hydrochloride 4.98 
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Observation:  
 Under these conditions, Minocycline hydrochloride eluted at the 
retention time of 4.98min, with peak fronting and broad peak shape. By observing 
this it can be concluded that even by changing the buffer strength of mobile phase, 
fronting could not be prevented. 
Trial-5 
In this trial, except for the change in organic phase 0.02%V/v/v formic acid: 
Methanol (70:30 v/v) and all the other conditions were maintained as above. 
Chromatographic conditions: 
Mobile phase 0.02%V/v/v Formic acid:Methanol (70:30v/v) 
Flow rate 1.0 mL/min 
Column Inertsil ODS Column (150x4.6 mm, 5µ) 
Detector wave length 220 nm 
Column temperature Ambient 
Injection volume 10μL 
Run time 7 min 
Diluent Water 
 
 Below is the minocycline hydrochloride chromatogram obtained with 
these conditions: 
0.0 1.0 2.0 3.0 4.0 5.0 min
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Fig. 2.6 Trial - 5 Chromatogram of standard Minocycline hydrochloride 
S.NO Name of the peak Retention time (min) 
1 Minocycline hydrochloride 4.17 
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Observation: 
 Under these conditions, minocycline hydrochloride eluted at 4.17min 
with tailing factor below 2 and good peak symmetry. Hence the above conditions 
were established as the optimized method. 
Parameters of optimized method: 
Below are the parameters obtained with optimized LC conditions:  
Table 2.1 Parameters of optimized method 
Parameters Observation 
Minocycline hydrochloride 
Retention time 4.17 
Peak area 132583 
Theoretical plates 2050.591 
Tailing factor 1.695 
 
Acceptance criteria: 
 The theoretical plate number should be greater than 2000 
 The tailing factor should be less than 2 
Conclusion: 
 The parameters of minocycline hydrochloride peak obtained with the 
optimised method were found to be with in the acceptance criteria. 
 The retention time was satisfactory with shorter runtime and makes the 
proposed method was economical. 
 The peak shape was good and symmetric. 
Based on the peak parameters obtained, these LC conditions were further 
used in method validation.    
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6. RESULTS AND DISCUSSION 
Minocycline hydrochloride is a Broad spectrum tetracycline antibiotic. 
Chemically it is  (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-
tetrahydroxy-3,12-dioxo3,4,4a,5, 5a,6, 12,12a-octahydrotetracene-2-carboximidic 
acid hydrochloride and is used to treat Acne Vulgaris. 
Analytical methods have been reported in the literature for quantitative 
determination of Minocycline Hcl by HPLC, UPLC, UV Spectroscopy, and by LC-
MS. However, the so far reported HPLC methods for the estimation of Minocycline 
hydrochloride in bulk and pharmaceutical dosage forms used mobile phase 
combination of phosphate buffer and acetonitrile. Literature survey reveals that there 
were no validated RP-HPLC/PDA methods reported for the estimation of 
Minocycline hydrochloride in bulk, pharmaceutical dosage forms and in vitro 
dissolution samples compatible for LC-MS Methods. 
Hence, the present investigation was aimed at developing a validated RP-
HPLC-PDA method for the analysis of Minocycline hydrochloride in bulk, 
pharmaceutical dosage forms, accurate, precise and economical. 
METHOD OPTIMIZATION 
Mobile phase optimization was initially carried out with Inertsil ODS 
Column (150x4.6 mm, 5µ) using HPLC Water:Methanol(50:50). Minocycline 
hydrochloride peak was not eluted (Fig.2.2). In the next trial change in mobile phase  
0.02%V/v/v Formic acid:Acetonitrile (80:20v/v) were tried on the same column, 
Minocycline hydrochloride eluted with retention time of 3.36 min but peak fronting 
was observed (Fig.2.3). In next trial, with same column, change in the mobile phase 
ratio of 0.02%V/v/v Formic acid:Acetonitrile (85:15v/v). Minocycline hydrochloride 
eluted at 3.50 min, fronting was observed, the peak symmetry was not good and 
baseline drift was observed (Fig.2.4). In another trail change in ratio 0.02%V/v/v 
Formic acid:Acetonitrile (90:10v/v) was used. Minocycline hydrochloride peak 
shape was broad and peak fronting was observed (Fig.2.5). In the next trial change in  
mobile phase composition 0.02%V/v/v Formic acid:Methanol (70:30v/v), 
Minocycline hydrochloride peak eluted at 4.17  min, in this trial tailing factor was 
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below 2, fronting was not seen and the peak symmetry was good (Fig.2.6). For 
quantitative analytical purpose wavelength was set at 220 nm, which provided better 
reproducibility with minimum or no interference. The method was validated as per 
ICH Guidelines. The peak purity index of Minocycline hydrochloride was found to 
be greater than 0.9999 indicating peak purity of the drug sample used in the analysis 
and shown in (Figure-3.1). 
 The optimized chromatographic conditions were as follows: 
Mobile phase 0.02%V/v/v Formic acid:Methanol (70:30v/v) 
Flow rate 1.0 mL/min 
Mode of elution Isocratic 
Column Inertsil ODS Column (150x4.6 mm, 5µ) 
Detector wave length 220 nm 
Column temperature Ambient 
Injection volume 10L 
Run time 7 min 
Diluent                                 Water 
                     
 With the above developed conditions using 0.02%V/v/v Formic 
acid:Methanol (70:30v/v) as mobile phase with isocratic mode of elution program at 
1.0mL/min flow rate, the method was validated as per ICH guidelines. 
Assay/Analysis of the marketed formulation 
20 tablets were weighed individually and finely powdered. A powder blend 
equivalent to 10 mg of minocycline hydrochloride was transferred to a 10mL 
volumetric flask containing about 5mL of methanol, sonicated and made up to the 
mark with the same. The resulting solution was filtered through 0.45μm nylon 
membrane filter to obtain a stock solution of 1mg/mL. It was further diluted with 
diluent to get the required concentration (30μg/mL of minocycline hydrochloride). 
The solution was injected three times into the column. From the peak area obtained, 
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the content of minocycline hydrochloride in the tablets was calculated from the 
formula given in assay in method validation. The results were given in Table 3.8 and 
shown in Figure 3.48-3.50. The assay was found to be within the limits, indicating 
that the present LC conditions can be used for the assay of minocycline 
hydrochloride in different commercially available formulations. 
Acceptance Criteria: 
 The percentage assay for the drug should be 100% ±2. 
 % RSD of recoveries for the minocycline hydrochloride should be not more 
than 2. 
Table 3.8 Assay Results (n=3) 
Labeled amount 
(mg) 
Amount found (mg) 
(Mean±SD) 
% Assay % RSD 
Minocycline 
hydrochloride - 
50mg 
49.7±0.174 99.43 0.237 
    
 
METHOD VALIDATION 
          An integral part of analytical method development is validation. Once the 
method has been developed, it is necessary to evaluate under the conditions expected 
for real samples before being used for a specific purpose. The following parameters 
were evaluated.  
Specificity  
Specificity is the ability to assess unequivocally the analyte in the presence 
of components, which may be expected to be present. Typically, these might include 
impurities, degradants and matrix etc. The effect of wide range of excipients and 
other additives usually present in the formulation of Minocycline hydrochloride in 
the determinations under optimum conditions were investigated. 
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Diluent, placebo, standard solution and sample solution were analyzed 
individually as per the method to examine interference. From the base shifted 
overlay of the chromatograms in Fig. 3.2 and the 3D plots of diluent, standard, 
placebo and formulation are shown in Fig. 3.3, it can be inferred that there were no 
co eluting or interfering peaks where drug peak eluted. This shows that the peak of 
analyte was pure and excipients in the formulation did not interfere with the analyte. 
The peak purity indices values of the standard and sample peaks were found to be 
greater than 0.9999 and these results were in good agreement with the above results. 
The peak purity index (1.0000) also confirms the absence of the impurities in pure 
Minocycline hydrochloride sample. The peak purity index of Minocycline 
hydrochloride was shown in Fig. 3.1. 
Acceptance Criteria: 
 Peak purity values should be greater than 0.999.  
 Purity angle should be less than purity threshold without having any signs of 
purity flags. 
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Fig. 3.1 Peak purity index* of Minocycline hydrochloride (* Peak Purity 
Index:1.000; Single Point Threshold :0.998903; Min.peak purity index:1097). 
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Fig. 3.2 (a)  Overlaid base shift chromatograms of A-Standard; B-Sample; C-
Placebo ; D-Diluent 
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Fig. 3.2 (b)  Overlay of the chromatograms of A-Standard; B-Sample; C-
Placebo; D-Diluent - without base shift 
   D 
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(1) 
 
(2) 
 
(3) 
                Fig. 3.3 3D plots of Diluent (1), Placebo (2), Standard (3) and Sample  
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Linearity  
 Linearity of an analytical procedure is its ability to obtain test results, which 
are directly proportional to the concentration (amount) of analyte in the sample. A 
linear relationship was evaluated across the range of 10-50µg/mL for Minocycline 
hydrochloride of the analytical procedure in triplicate. The range of concentrations 
was selected based on 80-120 % of the test concentration. Peak area and 
concentrations were subjected to least square regression analysis to calculate 
regression equation. The data of the calibration curve was given in Tables 3.1 and 
shown in Figures 3.4-3.10. 
Acceptance criteria 
 The correlation coefficient should be not less than 0.99. 
 % RSD should be not more than 2.0. 
Table 3.1 Linearity data for Minocycline hydrochloride (n=3) 
Concentration (μg/mL) Mean peak area with ± SD (%RSD) 
10 64979± 1042.599 (0.46) 
20 124765.3 ± 1054.358 (0.235) 
30 189453± 9008.116 (0.061) 
40 257763.3± 6810.138 (0.0287) 
50 325527.3 ±8679 .238 (0.124) 
REGRESSION EQUATION y = 13082x – 3730 
R 0.999 
R2 0.999 
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Fig. 3.4 Calibration curve for Minocycline hydrochloride 
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Fig. 3.5 Linearity chromatogram of standard 10µg/mL of 
minocycline hydrochloride 
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Fig. 3.6 Linearity chromatogram of standard 20µg/mL of 
minocycline hydrochloride 
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Fig. 3.7 Linearity chromatogram of standard 30µg/mL of  
minocycline hydrochloride 
                                                                                                                                                                                       
Chapter 6 Results and Discussion 
Dept.of Pharmaceutical Analysis, 50 J.K.K. Nattraja College of Pharmacy 
0.0 1.0 2.0 3.0 4.0 5.0 min
-10
0
10
20
30
40
mAU
220nm,4nm (1.00)
4.
1
86
 
Fig. 3.8 Linearity chromatogram of standard 40µg/mL 
minocycline hydrochloride 
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Fig. 3.9 Linearity chromatogram of standard 50µg/mL of minocycline 
hydrochloride 
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Fig. 3.10 Overlay of chromatograms of standard solution of minocycline 
hydrochloride at different concentrations (10-50 µg/mL of minocycline 
hydrochloride)  (a)with base shift (b)without base shift 
Observation 
The correlation coefficient and % RSD were found to be within the limits.  
Precision 
            The precision of an analytical procedure expresses the closeness of 
agreement (degree of scatter) between a series of measurements obtained from 
multiple sampling of the same homogeneous sample under the prescribed 
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conditions. Precision may be considered at three levels: repeatability, intermediate 
precision and reproducibility. Precision should be investigated using homogeneous, 
authentic samples. The precision of an analytical procedure is usually expressed as 
the variance, standard deviation or coefficient of variation of a series of 
measurements. Precision was measured in terms of repeatability of application 
(System precision) and measurement (Method precision). The precision of the 
method was ascertained from the peak areas of six replicate injections of a fixed 
concentration.  
System precision:  
           Repeatability of standard application was carried out using six 
replicates of the standard concentration 30μg/mL of Minocycline hydrochloride. The 
data was given in Table 3.2 and chromatograms shown in Figures 3.11-3.17. 
Acceptance Criteria: 
 % RSD of peak area should not be more than 2. 
 % RSD of retention time should not be more than 1. 
Table 3.2 System precision data of Minocycline hydrochloride 
Injection no. 
Peak Area                         Retention time 
Minocycline  
hydrochloride 
  Minocycline  
hydrochloride 
 
Injection 1 
Injection 2 
453254 
452956 
 4.181 
4.179 
Injection 3 454463  4.180 
Injection 4 452806  4.179 
Injection 5 454033  4.176 
Injection 6 452870  4.175 
Average 453397  4.178 
Standard 
deviation 
690.332  0.0023 
% RSD 0.152  0.055 
Chapter 6 Results and Discussion 
Dept.of Pharmaceutical Analysis, 53 J.K.K. Nattraja College of Pharmacy 
0.0 1.0 2.0 3.0 4.0 5.0 min
-10
-5
0
5
10
15
20
25
30
35
mAU
220nm,4nm (1.00)
4
.1
7
9
 
Fig. 3.11 System Precision chromatogram of standard minocycline 
hydrochloride -Injection 1 
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Fig. 3.12 System Precision chromatogram of standard minocycline 
hydrochloride -Injection 2 
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       Fig. 3.13 System Precision chromatogram of standard minocycline 
hydrochloride -Injection 3 
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     Fig. 3.14 System Precision chromatogram of standard minocycline 
hydrochloride -Injection 4 
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Fig. 3.15 System Precision chromatogram of standard minocycline 
hydrochloride -Injection 5 
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Fig. 3.16 System Precision chromatogram of standard minocycline 
hydrochloride -Injection 6 
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Fig. 3.17 (a) Overlay of system precision chromatograms of standard 
minocycline hydrochloride 
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Fig. 3.17 (b) Base shift overlay chromatogram of minocycline hydrochloride 
System precision data 
Observation 
 The % RSD was found to be below 2 for areas and below 1 for retention 
times and therefore fulfilled the ICH guidelines criteria. 
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Method precision: 
Repeatability of sample measurement was carried out in six replicates of the 
same sample preparations from same homogenous blend of marketed formulation. 
The data was given in Table 3.3 and chromatograms shown in Figures 3.18-3.24 
Acceptance Criteria: 
 % RSD of peak area should not be more than 2. 
 % RSD of retention time should not be more than 1. 
Table 3.3 Method precision data of Minocycline hydrochloride 
Injection no. 
Peak Area                     Retention time 
Minocycline 
hydrochloride 
 Minocycline 
hydrochloride 
Injection 1 443982  4.178 
Injection 2 442764  4.174 
Injection 3 446782  4.178 
Injection 4 443187  4.173 
Injection 5 444041  4.172 
Injection 6 443789  4.174 
Average 444091  4.1748 
Standard 
deviation 
1408.92  0.0025 
% RSD 0.3172  0.061 
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Fig. 3.18 Method Precision chromatogram of minocycline  
hydrochloride -Injection 1 
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Fig. 3.19 Method Precision chromatogram of minocycline  
hydrochloride -Injection 2 
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     Fig. 3.20 Method Precision chromatogram of minocycline  
hydrochloride -Injection 3 
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Fig. 3.21 Method Precision chromatogram of minocycline 
hydrochloride -Injection 4 
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 Fig. 3.22 Method Precision chromatogram of minocycline 
hydrochloride -Injection 5 
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Fig. 3.23 Method Precision chromatogram of 
minocycline hydrochloride -Injection 6 
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Fig. 3.24 (a) Overlay of method precision chromatograms of  
minocycline hydrochloride 
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Fig. 3.24 (b) Base shift overlay chromatogram of minocycline  
hydrochloride Method Precision data 
Observation 
The % RSD was found to be below 2 for areas and below 1 for retention 
times and therefore fulfilled the ICH guidelines criteria. 
Accuracy/Recovery 
The accuracy of an analytical procedure expresses the closeness of  
(b) 
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agreement between the value, which is accepted either as a conventional true value 
or an accepted reference value and the value found. Accuracy was tested (% 
Recovery and % RSD of individual measurements) by analyzing samples at least in 
triplicate, at each level (80,100 and 120% of label claim) is recommended. 
Accuracy of the method was examined by performing recovery studies by 
standard addition method for drug product as the exact components are unknown. 
For the drug substance, the analyte peak was evaluated by 3D plot of the 
chromatogram in order to confirm the existence of the components at 4.18 elution 
time of Minocycline Hcl as the impurities were not available. The recovery of the 
added standard to the drug product sample was calculated and it was found to be 
99.52-100.66%. The % RSD was less than 2, which indicate a good accuracy of the 
method to that of label claim. The obtained recovery results were given in table 3.4. 
From the 3D plots (in Fig 3.3) it is clear that the peaks eluted at 3.2 min (in standard 
chromatograms) are only one component, free of impurities. The data was given in 
Tables 3.4 and shown in Figures 3.25-3.33. 
Acceptance criteria: 
 The percent recoveries for Minocycline hydrochloride should be in between 98-
102. 
 % RSD of recoveries for Minocycline hydrochloride should be not more than 2. 
Table 3.4 Accuracy data for Minocycline hydrochloride (n=3) 
Serial 
No. 
% Level 
of 
Addition 
Amount 
Present 
(μg/mL) 
Amount 
Added 
(μg/mL) 
Amount 
found 
(μg/mL) 
% 
Recovery 
Mean %RSD 
1 80 
80 
80 
30 
30 
30 
24 
24 
24 
54.22 
54.17 
54.07 
100.757 
100.59 
100.23 
 
100.523 
 
0.264 
2 100 
100 
100 
       30 
30 
30 
30 
30 
30 
59.83 
59.98 
59.76 
99.45 
99.93 
99.20 
 
99.52 
 
0.372 
3 120 
120 
120 
30 
30 
30 
36 
36 
36 
65.94 
66.42 
66.23 
99.80 
101.40 
100.78 
 
100.66 
 
0.144 
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Fig. 3.25 Accuracy chromatogram of minocycline hydrochlorid 
at 80%-1 level of   addition 
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Fig. 3.26 Accuracy chromatogram of minocycline hydrochloride  
at 80% -2 level of   addition 
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Fig. 3.27 Accuracy chromatogram of minocycline hydrochloride 
at 80% -3 level of   addition 
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Fig. 3.28 Accuracy chromatogram of minocycline hydrochloride 
at 100%-1 level of addition 
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Fig. 3.29 Accuracy chromatogram of minocycline hydrochloride 
at 100%-2  level of addition 
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Fig. 3.30 Accuracy chromatogram of minocycline hydrochloride 
at 100%-3 level of addition 
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Fig. 3.31 Accuracy chromatogram of minocycline hydrochloride 
at 120%-1 level of addition 
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Fig. 3.32 Accuracy chromatogram of minocycline hydrochloride 
at 120%-2 level of addition 
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Fig. 3.33 Accuracy chromatogram of minocycline hydrochloride 
at 120%-3 level of addition 
Observation 
The obtained percent recoveries and % RSD value of minocycline 
hydrochloride was found to be within the limits indicating the accuracy of the 
proposed method. 
Robustness 
 The robustness of an analytical procedure is a measure of its capacity to 
remain unaffected by small, but deliberate variations in the method parameters and 
provides an indication of its reliability during normal usage. In the case of liquid 
chromatography, examples of typical variations are: 
 Influence of variations in mobile phase 
 Influence of variations in flow rate 
 Influence of variations in wave length 
 As a part of the robustness, deliberate changes in the flow rate and 
wavelength were made to evaluate the impact on the method. Changes in the flow 
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rate slightly affected the retention times of the Minocycline hydrochloride. However 
the parameters like, theoretical plate number and tailing factor were not changed and 
were within the limits. Similar results were obtained with the changed wavelength. 
The data was given in Tables 3.5 and shown Figures 3.34-3.39. 
Acceptance criteria: 
The robustness should pass as per the test method at variable conditions. 
Table 3.5 Robustness data for Minocycline hydrochloride 
Chromatographic parameter Retention 
time (min) 
Theoretical 
plates (#) 
Tailing 
factor (Tf) 
Flow rate    
0.95 4.377 2270.89 1.413 
1 4.285 2233.40 1.405 
1.05 4.286 2190.75 1.390 
Wave length (nm)    
218 4.185 2131.124 1.443 
220 4.185 2133.409 1.445 
222 4.185 2134.630      1.446 
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Fig. 3.34 Robustness chromatogram of minocycline hydrochloride at change in 
flow rate (0.95ml/min) 
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Fig. 3.35 Robustness chromatogram of minocycline hydrochloride at change in 
flow rate (1 ml/min) 
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Fig. 3.36 Robustness chromatogram of minocycline hydrochloride at change in 
flow rate (1.05ml/min) 
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Fig. 3.37 Robustness chromatogram of minocycline hydrochloride at 218nm     
wave length 
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Fig. 3.38 Robustness chromatogram of minocycline hydrochloride 
at 220nm wave length 
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Fig. 3.39 Robustness chromatogram of minocycline hydrochloride at 222nm 
wave length 
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Observation  
From the above results obtained, it was found that the robustness parameters 
were within the limits at all variable conditions. 
LOD and LOQ 
The detection limit (LOD) of an individual analytical procedure is the lowest 
amount of analyte in a sample, which can be detected but not necessarily quantified 
as an exact value. The quantification limit (LOQ) is a parameter of quantitative 
assay for low levels of compounds in sample matrices, and is used particularly for 
the determination of impurities and/or degradation products. The LOD and LOQ can 
be found based on 
1. Visual Evaluation  
2. Signal-to-Noise ratio 
3. The standard deviation of the response and the slope. 
In the present investigation, LOD and LOQ were determined from standard 
deviation and slope methods as per ICH guidelines and calculated from the average 
of slope and standard deviation (n=3) of the intercepts of the regression equation. 
LOD for Minocycline hydrochloride was found to be 0.6065µg/mL LOQ for 
Minocycline hydrochloride was found to be 1.838µg/mL, indicating good sensitivity 
of the method. 
System suitability  
System suitability testing is an integral part of any analytical procedures. The 
tests are based on the concept that the equipment, electronics, analytical operations, 
and samples to be analyzed constitute an integral system factor are parameters that 
are normally used in assessing the column performance. 
System suitability studies were carried out by injecting five times standard 
concentration of 10μg/mL (Minocycline hydrochloride) at different injection 
volumes ranging from 10L to 50L. The RSD values for system suitability test 
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parameters like retention time[Rt = 1.2560 for Minocycline hydrochloride], tailing 
factor [Tf = 1.2018  for Minocycline hydrochloride] and theoretical plate number 
[0.449 for Minocycline hydrochloride] were found to be less than 2% indicating the 
present conditions were suitable for the analysis of Minocycline hydrochloride in 
tablets. The data was given in Table 3.6 and Figures 3.40-3.45.  
Acceptance Criteria 
 Theoretical plate should be N>2000 
 Tailing factor should be T<2 
                       Table 3.6 System suitability data for Minocycline hydrochloride 
InjectionVol. (μL) Retention time 
(min) 
Tailing factor 
(Tf) 
Theoretical plate 
(#) 
10 4.175 1.426 2441.07 
20 4.212 1.381 2452.19 
30 4.244 1.471 2459.28 
40 4.279 1.408 2471.39 
50 4.310 1.412 2457.79 
Mean 4.244 1.4088 2456.346 
% RSD 1.2560 1.2018 0.449 
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Fig. 3.40 System suitability chromatogram of standard solution minocycline 
hydrochloride-10µL 
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Fig. 3.41 System suitability chromatogram of standard solution of minocycline 
hydrochloride-20µL 
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Fig. 3.42 System suitability chromatogram of standard solution of  
minocycline hydrochloride-30µL 
0.0 1.0 2.0 3.0 4.0 5.0 min
-25
0
25
50
75
100
125
150
mAU
220nm4nm (1.00)
4.
2
79
 
Fig. 3.43 System suitability chromatogram of standard solution of  
minocycline hydrochloride-40µL 
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Fig. 3.44 System suitability chromatogram of standard solution of minocycline 
hydrochloride-50µL 
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 min
-25000
0
25000
50000
75000
100000
125000
150000
175000
200000
uV
 
(a) 
Chapter 6 Results and Discussion 
Dept.of Pharmaceutical Analysis, 77 J.K.K. Nattraja College of Pharmacy 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 min
0
50000
100000
150000
200000
250000
300000
uV
 
Fig. 3.45 Overlay {(a) without base shift (b) with base shift} of System 
suitability   chromatograms of standard solution (10-50µL) of minocycline 
hydrochloride. 
Observation  
From the observation it was found that the system suitability test parameters 
were within limits for the proposed method. 
Stability of the Stock Solution  
The stability of the stock and standard solutions were determined by 
analyzing the samples under refrigeration (8±1°C) at different time intervals up to 24 
hours. The % variation in assay values at different time intervals were found to be 
less than 2 of the initial zero time interval solution, thus indicating that the solutions 
were stable for a period of 24 hours when stored at 8oC. The data was given in Table 
3.7 and shown in Figures 3.93-3.94. 
Table 3.7 Stability data for minocycline hydrochloride 
Time interval                             %Variation in peak area 
Minocycline hydrochloride 
0 hrs 446782 
24 hrs 443187 
            (b) 
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Fig. 3.46 Stability chromatogram of minocycline hydrochloride at 0 hr (30 
µg/mL of minocycline hydrochloride) 
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 Fig. 3.47 Stability chromatogram of minocycline hydrochloride at 24 hrs 
(30µg/mL of minocycline hydrochloride) 
Observation  
 From the results obtained, it was found that the %variation is less than 2. 
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Fig. 3.48 Assay chromatogram of formulation minocycline hydrochloride 
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Fig. 3.49 Assay chromatogram of formulation minocycline hydrochloride 
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Fig. 3.50 Assay chromatogram of formulation minocycline hydrochloride 
Observation 
 The percentage RSD value of assay for minocycline hydrochloride was 
within the limits. 
Chapter 7 Summary and Conclusion 
Dept.of Pharmaceutical Analysis, 81 J.K.K. Nattraja College of Pharmacy 
7. SUMMARY AND CONCLUSIONS 
 Minocycline hydrochloride is a broad-spectrum tetracycline antibiotic, 
chemically it is (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-
tetrahydroxy-3,12-dioxo-3,4,4a,5,5a,6, 12,12a-octahydrotetracene-2-carboximidic 
acid hydrochloride. Minocycline passes directly through the lipid bilayer or 
passively diffuses through porin channels in the bacterial membrane. Tetracyclines 
like minocycline bind to the 30S ribosomal subunit, preventing the binding of tRNA 
to the mRNA-ribosome complex and interfering with protein synthesis. The aim of 
this present investigation is to develop an efficient, rapid and sensitive RP-HPLC-
PDA method for the estimation of Minocycline hydrochloride in bulk, 
pharmaceutical dosage forms compatible for LC-MS methods and subsequent 
validation of the LC method as per ICH guidelines. 
METHOD DEVELOPMENT 
Finally these are the optimized conditions developed after performing suitable trials. 
Mobile phase                      :    0.02%V/v/v Formic acid:Methanol (70:30v/v) 
Flow rate                            :      1.0 mL/min 
Column                               :     Inertsil ODS Column (150x4.6 mm, 5µ) 
Type of elution                   :    Isocratic 
Detector wave length         :     220 nm 
Column temperature          :    Ambient 
Pressure observed              :      62 kgf 
Injection volume                :     10L 
Run time                            :     7 min 
With the optimized conditions mentioned above, peak was eluted at 4.17 
min, with good peak symmetry and with acceptable results of system suitability 
parameters. 
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METHOD VALIDATION 
Specificity 
The specificity of the method was established by spiking solution of commonly 
used excipients. Peak purity tests were also carried out to show that the analyte 
chromatographic peak is not attributable to more than one component as the 
impurities are not available by purity index data, as there was no interference of 
impurities with the analyte peak. This shows that the peak of analyte was pure and 
excipients in the formulation did not interfere with the analyte.  
 From the chromatograms and 3 D plots it can be inferred that there were no co 
eluting or interfering peaks where minocycline hydrochloride was eluted and the 
peak purity value greater than 0.9999 for minocycline hydrochloride this showed 
that the method was specific. 
Linearity 
Linearity studies were performed at 10-50μg/mL of Standard drug solution of 
minocycline hydrochloride by constructing graph between concentrations vs. peak 
areas. % RSD of peak areas were determined. Correlation coefficient was calculated, 
the data found within the acceptance criteria of 0.99. 
 The result was found to be within limit so the method is linear over the 
concentration range of 10-50μg/mL of Minocycline hydrochloride. 
Precision  
Precision of related substances were verified by repeatability. Repeatability was 
assessed by using a minimum of six determinations at 100 % of the test 
concentration (30μg/mL of minocycline hydrochloride) standard deviation and 
relative standard deviation were reported for precision. 
 % RSD of area response of minocycline hydrochloride was 0.152 for system 
precision and 0.317 for method precision  
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 % RSD of retention times of minocycline hydrochloride was 0.055 for system 
precision and 0.061 for method precision  
 % RSD should be NMT 2 for areas and NMT 1 for retention times. It indicates 
that the method is precise. 
Accuracy 
Accuracy of the proposed method was ascertained by performing recovery 
studies by standard addition method by spiking the known quantities of standard at 
80%, 100%, 120% to the drug product solution comprising of 30µg/mL. The % RSD 
and the % Recovery were within the acceptable limits of 98-102 in all cases.  
 The recovery of minocycline hydrochloride was found to be 99.52-100.66%, 
which indicates a good accuracy of the method to that of the label claim. 
LOD &LOQ  
The quantification limit of individual analytical procedure is the lowest amount 
of analyte in the sample that can be determined quantitatively. LOD and LOQ were 
calculated from the average slope and standard deviation from the calibration curve.  
 LOD for minocycline hydrochloride was found to be 0.6065g/mL, indicating 
high sensitivity of the method. 
 LOQ for minocycline hydrochloride was found to be 1.838µg/mL, indicating 
high sensitivity of the method.   
Robustness  
As part of the robustness, deliberate changes in the flow rate and wavelength 
were made to evaluate the impact on the method. 
 The obtained results indicated that the minor changes in the flow rate and wave 
length did not affect the actual conditions. 
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System suitability 
System suitability was used to verify the reproducibility of the chromatographic 
system. To ascertain its effectiveness, system suitability were carried out on freshly 
prepared stock solution. System suitability parameters are evaluated by measuring 
the closeness of the obtained values % RSD for the parameters like tailing factor of 
minocycline hydrochloride was found to be 1.20, retention time of minocycline 
hydrochloride was found to be 1.25 and the theoretical plates of minocycline 
hydrochloride was found to be 0.449 
 The % RSD of tailing factor, retention time and theoretical plates of 
minocycline hydrochloride was found to be less than 2. 
Stability of the solution  
         The stability of the solutions was assessed by analysing the sample and 
standard solution at different time intervals up to 24 hours and the % variation of 
minocycline hydrochloride was found to be 0.293%. It was found out that the 
solution remained stable for 24 hours when stored at 8°C. 
 The Final value should be within 2% of the initial value. 
Assay 
The assay of Minocycline hydrochloride tablets was performed by comparing 
the areas of standard minocycline hydrochloride and tablet sample,  
 The percentage assay for minocycline hydrochloride was found to be 99.43%. 
 Assay was performed by the data was found suitable and within the acceptance 
range of 100 ± 2 %. 
The Table 4.1 below summarizes the results of various parameters of validation 
comparing the obtained results with the acceptance criteria.  
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Table 4.1   Summary of results of Validation Parameters 
Parameter Acceptance Criteria Result 
Specificity No interference from blank, 
placebo and other 
degradation products with 
the main peak. 
No interference from blank, 
placebo and other degradation 
products with the main peak. 
Peak purity index > 0.999 Peak purity index =0.9999 for 
Minocycline hydrochloride 
Linearity R2 > 0.99 R2 = 0.999 for Minocycline 
hydrochloride 
Precision 
System RSD of area < 2% RSD of area for Minocycline 
hydrochloride = 0.152 
Method RSD of area < 2% RSD of area for Minocycline 
hydrochloride = 0.317 
Accuracy 98- 102%     99.52-100.66 for 
Minocycline hydrochloride 
LOD S/N > 2 or 3 0.6065µg/mL for Minocycline 
hydrochloride 
LOQ S/N > 10       1.838µg/mL for 
Minocycline hydrochloride 
  Robustness No significant affect Slight variations in retention 
times 
System Suitability Tailing factor < 2 Tailing factor for Minocycline 
hydrochloride = 1.4088 
Theoretical plate number > 
2000 
Theoretical plate number for 
Minocycline hydrochloride = 
2456.346. 
Solution stability % variation< 2 for 24 hrs %variation of Minocycline 
hydrochloride = 0.293% 
Assay 98-100% 99.43% for Minocycline 
hydrochloride 
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Finally, it can be concluded that the proposed RP-HPLC-PDA method was 
validated fully as per the International Conference on Harmonization (ICH) 
Guidelines, and found to be applicable for routine quality control analysis for the 
estimation of Minocycline hydrochloride. The results of linearity, precision, 
accuracy and specificity proved to be within the limits. The method provides 
selective quantification of Minocycline hydrochloride without interference from 
blank, placebo and degradants. The proposed method is sensitive, reproducible, 
reliable, rapid, economical, and specific and LC-MS compatible, can be used for the 
estimation of Minocycline hydrochloride. 
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